Moreover, MiTF-depleted cells presented a cellular and chromosomal hypersensitivity to ICL-inducing agents similar to that reported in FANCA- or FANCD2-depleted melanoma cells (Fig. 2e,f, Supplementary Fig. 2c,d,e and data not shown). This evidence concerns the gene MITF and melanoma.